S059 Up-to-Date Treatment of Hair, Scalp and Nail Disorders
DESCRIPTION
This session is aimed to provide a very practical guide for the treatment of hair, scalp and nail disorders. It will discuss approved and off-label treatments for common and uncommon types of alopecia, and for common nail disorders. The session will discuss indications and efficacy of hair and nail procedures including intra-lesional injections, and lasers. It will also provide recommendations for treating and managing hair and nail disorders in patients of different ethnicities and genders, including transgender patients. Although focused to educate the younger audience, it will provide an up-to-date review for all providers.
LEARNING OBJECTIVES
Select best treatment for the patients with different types of alopecia
Differentiate procedures to utilize in patients with hair and nail disorders
Select best treatment for patients with nail disorders
SCHEDULE
1:00 PM
Welcome and introduction
Antonella Tosti, MD
1:05 PM
Update on oral minoxidil
Antonella Tosti, MD
1:12 PM
Hair oils: good or bad?
Boni E. Elewski, MD, FAAD
1:19 PM
Intralesional treatments in androgenetic alopecia
Maria Abril Martinez Velasco, MD
1:26 PM
GLP 1 inhibitors in the treatment of hair disorders
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
1:33 PM
Haircare recommendations for women of African descent
Yolanda M Lenzy, MD, FAAD
1:40 PM
Regenerative treatments for hair loss. When and how?
Maria K. Hordinsky, MD, FAAD
1:47 PM
Questions and answers
Antonella Tosti, MD, Boni E. Elewski, MD, FAAD, Maria K. Hordinsky, MD, FAAD, Yolanda M Lenzy, MD, FAAD, Maria Abril Martinez Velasco, MD, Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
2:03 PM
Hair transplantation in permanent alopecia from radiotherapy
Andrei Doroshkevich, MD, IFAAD
2:10 PM
Treatment of Central Centrifugal Cicatricial Alopecia
Amy J McMichael, MD, FAAD
2:17 PM
Female Pattern Hair Loss : an algorithm approach
Jerry Shapiro, MD, FAAD
2:24 PM
Treating hair loss in menopause
Paradi Mirmirani, MD, FAAD
2:31 PM
Treating of hair loss in transgender patients
Daniel Asz-Sigall, MD, IFAAD
2:38 PM
Treating hair loss in women with cancer
Fernanda Torres, MD, IFAAD
2:45 PM
questions and answers
Daniel Asz-Sigall, MD, IFAAD, Amy J McMichael, MD, FAAD, Paradi Mirmirani, MD, FAAD, Jerry Shapiro, MD, FAAD, Fernanda Torres, MD, IFAAD
3:00 PM
When a nail clipping is really important for treatment ?
Adam Rubin, MD, FAAD
3:07 PM
Nail lichen planus: new treatments
Brian William Morrison, MD, MSc, FAAD
3:14 PM
Best surgical approach to melanonychia
Nathaniel J. Jellinek, MD, FAAD
3:21 PM
My surgical tips
Martin N. Zaiac, MD, FAAD
3:28 PM
Intralesional nail injections when and how
Bertrand Richert, MD, PhD, IFAAD
3:35 PM
Management of subungual warts
Chinmanat Lekhavat, MD, PhD, IFAAD
3:42 PM
Questions and answers
Nathaniel J. Jellinek, MD, FAAD, Chinmanat Lekhavat, MD, PhD, IFAAD, Brian William Morrison, MD, MSc, FAAD, Bertrand Richert, MD, PhD, IFAAD, Adam Rubin, MD, FAAD, Martin N. Zaiac, MD, FAAD
DIRECTOR
Antonella Tosti, MD
SPEAKERS
Daniel Asz-Sigall, MD, IFAAD
Andrei Doroshkevich, MD, IFAAD
Boni E. Elewski, MD, FAAD
Maria K. Hordinsky, MD, FAAD
Nathaniel J. Jellinek, MD, FAAD
Chinmanat Lekhavat, MD, PhD, IFAAD
Yolanda M Lenzy, MD, FAAD
Maria Abril Martinez Velasco, MD
Amy J McMichael, MD, FAAD
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
Paradi Mirmirani, MD, FAAD
Brian William Morrison, MD, MSc, FAAD
Bertrand Richert, MD, PhD, IFAAD
Adam Rubin, MD, FAAD
Jerry Shapiro, MD, FAAD
Fernanda Torres, MD, IFAAD
Martin N. Zaiac, MD, FAAD
DISCLOSURES
Daniel Asz-Sigall, MD, IFAAD
No financial relationships exist with ineligible companies.
Andrei Doroshkevich, MD, IFAAD
No financial relationships exist with ineligible companies.
Boni E. Elewski, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Janssen-Ortho Inc. – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding);
Maria K. Hordinsky, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Cassiopea – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); McGraw-Hill Companies – Other(Fees); National Alopecia Areata Foundation – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Sun Pharmaceuticals – Investigator(Grants/Research Funding); UpToDate, Inc – Other(Fees); VeraDermics Inc. – Investigator(Grants/Research Funding);
Nathaniel J. Jellinek, MD, FAAD
No financial relationships exist with ineligible companies.
Chinmanat Lekhavat, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
Yolanda M Lenzy, MD, FAAD
CeraVe/Valeante – Other(Fees); Neutrogena – Consultant (1099 relationship)(Grants/Research Funding);
Maria Abril Martinez Velasco, MD
No financial relationships exist with ineligible companies.
Amy J McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Paradi Mirmirani, MD, FAAD
Amgen – Investigator(Grants/Research Funding); Cicatricial Alopecia Research Foundation – Advisory Board(No Compensation Received); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Priovant Therapeutics – Consultant (1099 relationship)(Fees); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); UpToDate, Inc – Other(Patent royalties or other compensation for Intellectual Property Rights); VeraDermics Inc. – Advisory Board(Honoraria);
Brian William Morrison, MD, MSc, FAAD
No financial relationships exist with ineligible companies.
Bertrand Richert, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
Adam Rubin, MD, FAAD
New York University Langone Medical Center – Employee – Lab does not sell products(Salary);
Jerry Shapiro, MD, FAAD
30 Madison – Consultant (1099 relationship)(Stock Options); Almirall – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria);
Fernanda Torres, MD, IFAAD
No financial relationships exist with ineligible companies.
Antonella Tosti, MD
Almirall – Advisory Board(Fees); Amgen – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Concert Pharmaceuticals – Investigator(Salary); DS Laboratories – Consultant(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Salary); L'Oreal USA Inc. – Advisory Board(Honoraria); Myovant Sciences – Advisory Board(Fees); Ortho Dermatologics – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Honoraria); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); Taylor & Francis – Other(Patent royalties or other compensation for Intellectual Property Rights); The WellBeauty Company, LLC – Consultant (1099 relationship)(Fees); Thirty Madison, Inc. – Consultant(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);
Martin N. Zaiac, MD, FAAD
No financial relationships exist with ineligible companies.